Free Cash Flow - Corcept Therapeutics Inc (NASDAQ:CORT) - Alpha Spread

Corcept Therapeutics Inc
NASDAQ:CORT

Watchlist Manager
Corcept Therapeutics Inc Logo
Corcept Therapeutics Inc
NASDAQ:CORT
Watchlist
Price: 43.93 USD 1.5% Market Closed
Market Cap: 4.8B USD
Have any thoughts about
Corcept Therapeutics Inc?
Write Note

Corcept Therapeutics Inc
Free Cash Flow

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Corcept Therapeutics Inc
Free Cash Flow Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
Corcept Therapeutics Inc
NASDAQ:CORT
Free Cash Flow
$123.3m
CAGR 3-Years
-3%
CAGR 5-Years
2%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Free Cash Flow
$20.3B
CAGR 3-Years
-3%
CAGR 5-Years
2%
CAGR 10-Years
3%
Bristol-Myers Squibb Co
NYSE:BMY
Free Cash Flow
$12.9B
CAGR 3-Years
3%
CAGR 5-Years
16%
CAGR 10-Years
14%
Pfizer Inc
NYSE:PFE
Free Cash Flow
$4.8B
CAGR 3-Years
-38%
CAGR 5-Years
-16%
CAGR 10-Years
-12%
Merck & Co Inc
NYSE:MRK
Free Cash Flow
$13.1B
CAGR 3-Years
34%
CAGR 5-Years
11%
CAGR 10-Years
2%
Eli Lilly and Co
NYSE:LLY
Free Cash Flow
-$3.6B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Corcept Therapeutics Inc's Free Cash Flow?
Free Cash Flow
123.3m USD

Based on the financial report for Jun 30, 2024, Corcept Therapeutics Inc's Free Cash Flow amounts to 123.3m USD.

What is Corcept Therapeutics Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
2%

Over the last year, the Free Cash Flow growth was -8%. The average annual Free Cash Flow growth rates for Corcept Therapeutics Inc have been -3% over the past three years , 2% over the past five years .

Back to Top